156
Participants
Start Date
September 30, 2015
Primary Completion Date
June 13, 2018
Study Completion Date
July 15, 2018
Flortaucipir F18
370 megabecquerel (MBq) IV single-dose
PET Scan
positron emission tomography (PET) scan
University of Melbourne, Parkville
Adirondack Medical Research Center, Glens Falls
Clarity Clinical Research, LLC, Syracuse
Wake Forest School of Medicine, Winston-Salem
Duke University Medical Center, Durham
Emory University Brain Health Center, Atlanta
Bioclinica, Orlando
Merritt Island Medical Research, Merritt Island
Galiz Research, Hialeah
Miami Jewish Health Systems, Miami
D de la Vega MD Research Group, Miami
Neuropsychiatric Research Center of Southwest Florida, Fort Myers
Hospice of the Western Reserve, Cleveland
Valley Medical Primary Care, Centerville
American Clinical Trials, LLC (Site 1216), Oklahoma City
Oklahoma Behavioral Health, Oklahoma City
Houston Methodist Research Institute, Houston
Sante Clinical Research, Kerrville
Banner Alzheimer's Institute, Phoenix
St. Joseph's Hospital and Medical Center, Phoenix
Steinberg Diagnostics, Henderson
California Research Foundation, San Diego
Pacific Research Network, San Diego
Hoag Memorial Hospital Presbyterian, Newport Beach
Syrentis Clinical Research, Santa Ana
Ray Dolby Brain Health Center, San Francisco
Cherlin Research, Los Gatos
Overlake Internal Medicine Associates, PS, Bellevue
University of Washington Medicine, Seattle
Alzheimer's Disease Center, Quincy
Rhode Island Hospital, Providence
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY